Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Innovative antiviral substances: the first effective method of treatment of enterovirus infections
| Reference number | 2017-04495 |
| Coordinator | Curovir AB |
| Funding from Vinnova | SEK 900 000 |
| Project duration | November 2017 - November 2018 |
| Status | Completed |
| Venture | Innovative Startups |
